Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- User; By Region; Segment Forecast, 2023-2032

Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- User; By Region; Segment Forecast, 2023-2032



The global darier disease market size is expected to reach USD 74.12 million by 2032, according to a new study by Polaris market research. The report “Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- Use; By Region; Segment Forecast, 2023-2032” gives a detailed insight into the current market dynamics and provides analysis on future market growth.

Darier disease is anticipated to spread as new healthcare trends emerge. More dermatological treatments will be available to address the condition's side effects, and researchers will receive sizeable financial support to create novel remedies. Darier disease, or keratosis follicularis, is a rare genetic skin disorder caused by mutations in the ATP2A2 gene. The disease is characterized by wart-like papules and plaques that typically appear on the scalp, forehead, chest, back, and other body areas.

Due to the condition's rarity, the market for Darier disease is quite small. Yet, certain businesses, including Castle Creek Pharmaceuticals & Hoth Therapeutics, are focused on creating treatments for uncommon skin conditions. The fact that some of the medications used to treat Darier disease, including retinoids and calcineurin inhibitors, are also used to treat other skin disorders may help to increase the market for these medications.

However, the small patient population and the high cost of developing rare disease therapies may limit the number of companies investing in this area. The COVID-19 pandemic has significantly impacted the healthcare industry, with many healthcare providers and facilities focused on treating patients with COVID-19. This has led to delays in diagnosing and treating other medical conditions, including rare diseases like Darier disease. Additionally, the pandemic has disrupted clinical trials and drug development programs, which may impact the availability of new treatments for Darier disease. Many trials have been delayed or suspended due to safety concerns and restrictions on patient access to healthcare facilities.

Darier Disease Market Report Highlights

Surgery is expected to dominate the industry's market sector during forecast period. The ability of the surgical industry to reduce pain and discomfort while improving results is the major factor driving its expansion.

Topical Retinoid will account for a higher share of the market in the upcoming year. Due to the effectiveness of these medications in treating the condition's symptoms, the primary driver driving the market is predicted to grow over the next several years.

Dermatologist accounted for the largest share in 2022. They are the primary force influencing the market because they are in charge of prescribing, offering patient support, and playing a crucial part in the care of this ailment.

The demand in North America is expected to witness significant growth during forecast period. The primary driver of the market is anticipated to rise in the upcoming years as a result of a number of factors, including the expansion of healthcare service options and rising healthcare costs.

Polaris Market Research has segmented the Darier Disease Market report based on treatment, application, end- user and region:

Darier Disease, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

Medical

Surgery

Others

Darier Disease, Application Outlook (Revenue - USD Million, 2019 - 2032)

Topical Retinoids

Oral Retinoids

Others

Darier Disease, End- User Outlook (Revenue - USD Million, 2019 - 2032)

Dermatologist

Homecare

Hospitals

Specialty Clinics

Darier Disease, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Darier Disease Market Insights
4.1. Darier Disease Market – End- User Snapshot
4.2. Darier Disease Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increase in demand for renewable sources of energy
4.2.1.2. Rise in demand for electricity consumption
4.2.2. Restraints and Challenges
4.2.2.1. High initial costs
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Darier Disease Market End- User Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Darier Disease Market, by Treatment
5.1. Key Findings
5.2. Introduction
5.2.1. Global Darier Disease Market, by Treatment, 2019-2032 (USD Million)
5.3. Medical
5.3.1. Global Darier Disease Market, by Medical, by Region, 2019-2032 (USD Million)
5.4. Surgery
5.4.1. Global Darier Disease Market, by Surgery, by Region, 2019-2032 (USD Million)
5.5. Others
5.5.1. Global Darier Disease Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Darier Disease Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Darier Disease Market, by Application, 2019-2032 (USD Million)
6.3. Topical Retinoids
6.3.1. Global Darier Disease Market, by Topical Retinoids, by Region, 2019-2032 (USD Million)
6.4. Oral Retinoids
6.4.1. Global Darier Disease Market, by Oral Retinoids, by Region, 2019-2032 (USD Million)
6.5. Others
6.5.1. Global Darier Disease Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Darier Disease Market, by End- User
7.1. Key Findings
7.2. Introduction
7.2.1. Global Darier Disease Market, by End- User, 2019-2032 (USD Million)
7.3. Dermatologist
7.3.1. Global Darier Disease Market, by Dermatologist, By Region, 2019-2032 (USD Million)
7.4. Homecare
7.4.1. Global Darier Disease Market, by Homecare, By Region, 2019-2032 (USD Million)
7.5. Hospitals
7.5.1. Global Darier Disease Market, by Hospitals, By Region, 2019-2032 (USD Million)
7.6. Specialty Clinics
7.6.1. Global Darier Disease Market, by Specialty Clinics, By Region, 2019-2032 (USD Million)
8. Global Darier Disease Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
8.3. Darier Disease Market – North America
8.3.1. North America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.3.2. North America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.3.3. North America: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.3.4. Darier Disease Market – U.S.
8.3.4.1. U.S.: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.3.4.2. U.S.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.3.4.3. U.S.: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.3.5. Darier Disease Market – Canada
8.3.5.1. Canada: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.3.5.2. Canada.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.3.5.3. Canada: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.4. Darier Disease Market – Europe
8.4.1. Europe: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.4.2. Europe.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.4.3. Europe: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.4.4. Darier Disease Market – UK
8.4.4.1. UK: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.4.4.2. UK.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.4.4.3. UK: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.4.5. Darier Disease Market – France
8.4.5.1. France: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.4.5.2. France.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.4.5.3. France: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.4.6. Darier Disease Market – Germany
8.4.6.1. Germany: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.4.6.2. Germany.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.4.6.3. Germany: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.4.7. Darier Disease Market – Italy
8.4.7.1. Italy: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.4.7.2. Italy.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.4.7.3. Italy: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.4.8. Darier Disease Market – Spain
8.4.8.1. Spain: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.4.8.2. Spain.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.4.8.3. Spain: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.4.9. Darier Disease Market – Netherlands
8.4.9.1. Netherlands: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.4.9.2. Netherlands.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.4.9.3. Netherlands: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.4.10. Darier Disease Market – Russia
8.4.10.1. Russia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.4.10.2. Russia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.4.10.3. Russia: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.5. Darier Disease Market – Asia Pacific
8.5.1. Asia Pacific: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.5.2. Asia Pacific.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.5.3. Asia Pacific: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.5.4. Darier Disease Market – China
8.5.4.1. China: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.5.4.2. China.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.5.4.3. China: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.5.5. Darier Disease Market – India
8.5.5.1. India: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.5.5.2. India.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.5.5.3. India: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.5.6. Darier Disease Market – Malaysia
8.5.6.1. Malaysia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.5.6.2. Malaysia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.5.6.3. Malaysia: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.5.7. Darier Disease Market – Japan
8.5.7.1. Japan: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.5.7.2. Japan.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.5.7.3. Japan: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.5.8. Darier Disease Market – Indonesia
8.5.8.1. Indonesia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.5.8.2. Indonesia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.5.8.3. Indonesia: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.5.9. Darier Disease Market – South Korea
8.5.9.1. South Korea: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.5.9.2. South Korea.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.5.9.3. South Korea: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.6. Darier Disease Market – Middle East & Africa
8.6.1. Middle East & Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.6.2. Middle East & Africa.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.6.3. Middle East & Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.6.4. Darier Disease Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.6.4.2. Saudi Arabia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.6.4.3. Saudi Arabia: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.6.5. Darier Disease Market – UAE
8.6.5.1. UAE: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.6.5.2. UAE.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.6.5.3. UAE: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.6.6. Darier Disease Market – Israel
8.6.6.1. Israel: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.6.6.2. Israel.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.6.6.3. Israel: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.6.7. Darier Disease Market – South Africa
8.6.7.1. South Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.6.7.2. South Africa.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.6.7.3. South Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.7. Darier Disease Market – Latin America
8.7.1. Latin America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.7.2. Latin America.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.7.3. Latin America: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.7.4. Darier Disease Market – Mexico
8.7.4.1. Mexico: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.7.4.2. Mexico.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.7.4.3. Mexico: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.7.5. Darier Disease Market – Brazil
8.7.5.1. Brazil: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.7.5.2. Brazil.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.7.5.3. Brazil: Darier Disease Market, by Application, 2019-2032 (USD Million)
8.7.6. Darier Disease Market – Argentina
8.7.6.1. Argentina: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
8.7.6.2. Argentina.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
8.7.6.3. Argentina: Darier Disease Market, by Application, 2019-2032 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. AbbVie
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Amneal Pharmaceuticals
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Bausch Health Companies
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. BridgeBio Pharma
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Galderma
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. GlaxoSmithKline
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Glenmark Pharmaceuticals
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Johnson and Johnson
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Laminar Pharma
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Mayne Pharma
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Merck
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Novartis
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Pfizer
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. Sawai Pharmaceutical
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. Sigmapharm Laboratories
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development
10.16. Sun Pharmaceutical
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Recent Development
10.17. Teva Pharmaceutical
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Recent Development
10.18. Tolmar Pharmaceuticals
10.18.1. Company Overview
10.18.2. Financial Performance
10.18.3. Product Benchmarking
10.18.4. Recent Development
10.19. Validus Pharmaceuticals
10.19.1. Company Overview
10.19.2. Financial Performance
10.19.3. Product Benchmarking
10.19.4. Recent Development
10.20. Viatris
10.20.1. Company Overview
10.20.2. Financial Performance
10.20.3. Product Benchmarking
10.20.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings